Toxoplasmosis in Cats and Humans: Transmission, Clinical Signs, and Public Health Implications

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii [1, 2]. Felids, including domestic cats (Felis catus), serve as the definitive hosts in which the parasite completes its sexual life cycle and sheds environmentally resistant oocysts [3, 4]. All warm-blooded vertebrates, including humans, can act as intermediate hosts [5, 6]. The parasite infects an estimated one-third of the global human population, making it one of the most prevalent parasitic infections worldwide [7, 8]. Despite decades of research, many aspects of T. gondii biology, transmission dynamics, and host interactions remain active areas of investigation [3, 9, 10]. This review provides a detailed examination of the parasite's life cycle, transmission routes, clinical signs in both cats and humans, diagnostic approaches, treatment strategies, and public health implications, with particular attention to common misconceptions surrounding the so-called "toxoplasmosis cat lady disease."

Life Cycle of Toxoplasma gondii

T. gondii exists in three infectious stages: tachyzoites (rapidly dividing forms), bradyzoites (slowly dividing forms contained within tissue cysts), and sporozoites (within oocysts) [2, 4]. The life cycle involves both sexual reproduction in the feline intestinal epithelium and asexual reproduction in a wide range of intermediate hosts [3, 9].

Cats become infected after ingesting tissue cysts from intermediate hosts (e.g., rodents, birds) or, less commonly, after ingesting sporulated oocysts from the environment [11, 12]. Once ingested, bradyzoites are released from tissue cysts and invade enterocytes, where they undergo multiple rounds of asexual replication (schizogony) [4]. After several days, the parasite commits to sexual development, producing male microgametes and female macrogametes [3, 9]. Fertilization results in the formation of unsporulated oocysts, which are shed in the feces [4]. Shedding typically begins 3–10 days after primary infection and can last 1–3 weeks, during which millions of oocysts may be excreted [13, 12]. Oocysts sporulate in the environment within 1–5 days, becoming infectious [4].

Intermediate hosts acquire infection by ingesting sporulated oocysts (contaminated soil, water, or food) or tissue cysts (undercooked meat) [5, 14, 15]. After ingestion, sporozoites or bradyzoites convert to tachyzoites, which disseminate throughout the body, eventually encysting in tissues such as the brain, skeletal muscle, and myocardium [7, 16, 10].

The following Mermaid diagram summarizes the sexual and asexual life cycles.

flowchart TD
    A[Definitive host: Cat], >|Ingests tissue cysts from prey| B[Bradyzoites released in intestine]
    B, > C[Asexual replication schizogony]
    C, > D[Sexual differentiation]
    D, > E[Unsporulated oocysts shed in feces]
    E, > F[Oocysts sporulate in environment]
    F, > G[Intermediate hosts ingest sporulated oocysts]
    G, > H[Tachyzoites disseminate and encyst as bradyzoites]
    H, >|Predation| A

Routes of Transmission

Fecal–Oral and Zoonotic Transmission

The primary route of human infection with T. gondii is oral ingestion of sporulated oocysts from contaminated environmental sources or consumption of undercooked meat containing tissue cysts [17, 14, 8]. Cats are the only hosts that shed oocysts, making them the cornerstone of environmental contamination [13, 4, 18]. Oocysts can survive for months in soil, water, and sand, and are resistant to many disinfectants [13, 19].

Direct contact with cat feces is not the most common route of human infection. Rather, accidental ingestion of oocysts through unwashed hands after gardening, cleaning litter boxes, or exposure to contaminated fruits and vegetables poses a greater risk [14, 20]. Additionally, waterborne outbreaks due to oocyst contamination of drinking water supplies have been documented [5, 21].

Vertical Transmission

Transplacental transmission occurs in both cats and humans when a pregnant female acquires a primary T. gondii infection during gestation [17, 21, 8]. In cats, vertical transmission can result in neonatal toxoplasmosis [22]. In humans, congenital toxoplasmosis can cause miscarriage, stillbirth, or severe neurological and ocular sequelae in the newborn [17, 8]. Seroprevalence studies have demonstrated the importance of screening in pregnant women [17, 20, 8].

Other Routes

Blood transfusion and organ transplantation from infected donors can transmit tachyzoites [23, 24]. Consumption of unpasteurized goat milk or raw cow milk has been identified as a potential but less common route [15]. Zoonotic transmission through handling of infected meat is a particular risk for slaughterhouse workers and veterinarians [25, 5].

Clinical Signs in Cats

Most cats infected with T. gondii remain subclinical [12, 26, 22]. Clinical disease occurs more frequently in kittens, immunosuppressed cats, or those co-infected with feline retroviruses such as feline leukemia virus (FeLV) [22].

The clinical signs are highly variable and depend on the organ systems affected by uncontrolled tachyzoite replication. The most common manifestations include:

• Ocular disease: uveitis, chorioretinitis, and anterior chamber inflammation [27, 16].
• Neurological signs: ataxia, seizures, tremors, cranial nerve deficits, and lethargy [28, 22].
• Respiratory signs: dyspnea, cough, and pneumonitis due to pulmonary involvement.
• Gastrointestinal signs: diarrhea, vomiting, and icterus associated with hepatitis or pancreatitis.
• Musculoskeletal signs: myositis, weakness, and lameness.

A summary of clinical presentations is provided in Table 1.

Table 1: Clinical Signs of Toxoplasmosis in Cats

Clinical Signs in Humans

In immunocompetent individuals, acute toxoplasmosis is usually asymptomatic or presents as a mild, self-limiting febrile illness with lymphadenopathy, fatigue, and myalgia [7, 16, 29]. However, primary infection during pregnancy poses the greatest risk for vertical transmission and fetal damage [17, 14, 8]. Congenital infection can lead to intracranial calcifications, hydrocephalus, microcephaly, chorioretinitis, and cognitive impairment [21, 8].

Ocular toxoplasmosis, characterized by necrotizing retinochoroiditis, is a major cause of vision loss in some regions and can occur after congenital or acquired infection [16, 29]. In immunocompromised individuals, such as organ transplant recipients or patients with malignancies, reactivation of latent tissue cysts can cause severe cerebral toxoplasmosis (encephalitis, mass lesions) or disseminated disease [24, 30].

Diagnosis

Serological Assays

Detection of anti-T. gondii antibodies (IgG, IgM, IgA) is the most commonly used diagnostic approach in both cats and humans [1, 31, 12, 18]. Various formats exist, including commercial ELISA kits, indirect fluorescent antibody tests, and agglutination tests. The double-antigen sandwich colloidal gold immunochromatographic strip assay, based on SAG1 and other surface antigens, has been developed for rapid point-of-care testing in multiple host species [1, 31]. In cats, the detection of IgM or rising IgG titers is indicative of recent or active infection [27, 26].

Molecular Detection

Polymerase chain reaction (PCR) assays amplify T. gondii DNA from blood, cerebrospinal fluid, aqueous humor, or tissues [13, 28]. Antisense PCR has been developed to improve sensitivity in feline samples [28]. Real-time PCR can quantify parasite load and differentiate between acute and chronic infection [13]. PCR of fecal samples is useful for detecting oocyst shedding in cats, although sensitivity varies with sampling time [13].

Histopathology and Cytology

Direct visualization of tachyzoites in cytological preparations (e.g., bronchoalveolar lavage, cerebrospinal fluid, liver aspirates) or histopathological sections is confirmatory but not always feasible [27, 22]. Immunohistochemical staining enhances sensitivity.

Treatment and Control

In cats with clinical toxoplasmosis, therapy includes clindamycin (the drug of choice), trimethoprim-sulfonamide combinations, or pyrimethamine plus a sulfonamide [22]. Supportive care and management of concurrent immunosuppressive conditions are essential.

A vaccine for feline toxoplasmosis is available in some regions, using inactivated or recombinant antigen preparations. The GRA12 recombinant vaccine has shown immunogenicity and protective efficacy in domestic cats [32]. Vaccination in captive wildlife has been associated with reduced mortality [33]. However, no licensed human vaccine exists; experimental subunit and mRNA vaccines have shown promise in animal models [2].

Preventive measures in cats include keeping them indoors to reduce hunting, feeding only cooked or commercial food, and regular cleaning of litter boxes [11, 14, 18]. Proper hygienic practices in pregnancy are critical: pregnant women should avoid cleaning litter boxes or wear gloves and wash hands thoroughly [14, 20].

Public Health Implications and Misconceptions

Toxoplasmosis Cat Lady Disease: A Misnomer

The colloquial term "toxoplasmosis cat lady disease" misleadingly implies that owning cats is the primary risk factor for human infection [14]. While cats are the definitive hosts, direct contact with a pet cat is rarely responsible for transmission. The majority of human infections arise from consumption of undercooked meat (especially pork, lamb, and game) or ingestion of oocysts from contaminated soil, water, or produce [5, 20, 15]. In fact, multiple epidemiological studies have found no significant association between cat ownership and T. gondii seropositivity in humans after adjusting for dietary and environmental confounders [11, 19, 18]. The stereotype may also contribute to unfair stigmatization of individuals with multiple cats.

One Health Considerations

T. gondii circulates in complex ecological networks involving wildlife, livestock, companion animals, and humans [6, 19, 34, 35]. Seroprevalence in wild felids and European bison underscores the parasite's ability to persist in natural ecosystems [34, 35]. Stray cat populations contribute to environmental oocyst contamination in urban areas [13, 18]. Integrated control strategies require veterinary, public health, and environmental management collaboration [2, 14].

Population-Level Impact

Congenital toxoplasmosis remains a substantial disease burden in low-resource settings, with incidence rates exceeding 1 per 1000 live births in some regions [21, 8]. Screening programs in pregnant women are cost-effective but not universally implemented. The association between childhood toxoplasmosis and neuropsychiatric outcomes, including psychotic experiences, has been explored but requires further investigation [7].

References

[1] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/

[2] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[3] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[4] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[5] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[6] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[7] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643571/

[8] Walana W, Odai SA, Tamomh AG. Prevalence, risk factors, diagnosis and outcomes of Toxoplasma gondii infection in pregnancy: A review. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40818495/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[9] Cancela S, Sena F, Pagotto R, et al. Enhancing pre-sexual and sexual differentiation of Toxoplasma gondii using retinal epithelial cells and intestinal organoids. Cell Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41108686/

[10] Schanz ML, Zhao F, Zadeii KE, et al. The cat's out of the bag: Toxoplasma gondii provides further insight into myeloid-mediated host defense. Immunohorizons. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40854593/

[11] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[12] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[13] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[14] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/

[15] Khosravi S, Hajipour N, Moosavy MH, et al. Survival Rate of Toxoplasma gondii Tachyzoites in Cow's Milk at Different Temperatures. Vet Med Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40884309/

[16] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603939/

[17] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/

[18] Lider LA, Kiyan V, Mannapova NE, et al. Seroprevalence of Toxoplasma gondii infection in urban client-owned cats in Kazakhstan. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40875169/

[19] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41401226/

[20] Tahita MC, Kaboré B, Ilboudo H, et al. Toxoplasma gondii seroprevalence and associated factors among pregnant women attending their first antennal care visit in rural Burkina Faso. J Parasit Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40901422/

[21] Minani S, Di Bari C, Devleesschauwer B, et al. Assessing the burden of congenital toxoplasmosis in Burundi, 2020. Acta Trop. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40915592/

[22] Fonseca J, Almeida P, Campos S, et al. Identification of a mouse-virulent recombinant type I/III Toxoplasma gondii strain in liver cytology of an immunosuppressed cat infected with FeLV-C subgroup. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41108469/

[23] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/

[24] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[25] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[26] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41471183/

[27] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[28] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[29] Pielok Ł, Sałamatin R, Swarcewicz J, et al. Toxocarosis, toxoplasmosis and ocular dirofilariasis diagnosed in a polish farmer from Wielkopolska Voivodeship - a case description. BMC Ophthalmol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41225401/

[30] Roya SK, Maryam ER, Ahmad H, et al. Investigation of the Prevalence of Toxoplasmosis in Patients with Malignancies, Southwest of Iran. Arch Razi Inst. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41179623/

[31] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[32] Yang J, Nie L, Song Y, et al. Immunogenicity and Protective Efficacy of a Recombinant Toxoplasma gondii GRA12 Vaccine in Domestic Cats. Vaccines (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40872935/

[33] Scuotto A, Ogonczyk-Makowska D, Quiévy A, et al. Retrospective Analysis of the Impact of Vaccination with an Inactivated Vaccine on Toxoplasmosis-Associated Mortality in Captive Wildlife. Vaccines (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41012115/

[34] Didkowska A, Kołodziej-Sobocińska M, Matusik K, et al. Toxoplasma gondii in wild felides in Poland. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41387866/

[35] Kołodziej-Sobocińska M, Holec-Gąsior L, Ferra B, et al. A long-term serological survey of Toxoplasma gondii in European bison (Bison bonasus) - the largest european herbivore. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41359089/